Merck (MRK) stock will be in focus as company inks deal worth up to $3.3B to buy licensing rights to a cancer candidate ...
The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback